BARD1 and breast carcinoma: To determine whether Vorinostat-induced BARD1 down-regulation was an exclusive event of human AML cells, we evaluated BARD1 expression levels in other human cancer models, such as MCF7 breast cancer cells, HeLa cervical cancer cells and Kelly neuroblastoma cells.